Asahi Kaisei Corp, AW Technologies enter exclusive distribution agreement

AW Technologies and Asahi Kasei Medical have entered into an exclusive distribution agreement in Japan for AW Technologies’ TrachFlush device. AW Technologies is currently in the process of medical device registration of the TrachFlush in Japan, with market launch targeted in fiscal 2024. Ken Shinomiya, President of Asahi Kasei Medical, stated, “We are delighted to add the TrachFlush to our product lineup in the intensive care field, where we have strength in the area of blood purification. By leveraging our experience and know-how in blood purification, we believe that this will deliver diverse value, such as enhancing patients’ QOL and reducing the burden on healthcare workers.”